Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Sales, net	$ 33,623	$ 36,604
Cost of sales	28,122	28,997
Gross profit	5,501	7,607
Selling and administrative expenses	4,385	8,113
Operating income (loss)	1,116	(506)
Other income (expense), net:
Interest expense	(979)	(1,109)
Forbearance fees		(1,100)
Change in fair value of deriative instruments	(133)	9
Impairment charge on investment in iBio, Inc.	(139)
Other income (expense), net	245	4
Total other expense, net	(1,006)	(2,196)
Income (loss) before income taxes	110	(2,702)
Income tax expense, net	17	11
Net income (loss)	$ 93	$ (2,713)
Basic net income (loss) per common share (in Dollars per share)	$ 0.00	$ (0.13)
Diluted net income (loss) per common share (in Dollars per share)	$ 0.00	$ (0.13)
Weighted average common shares outstanding - basic (in Shares)	21,080,174	21,011,522
Equivalent shares outstanding (in Shares)	163,456
Weighted average common shares outstanding - diluted (in Shares)	21,243,630	21,011,522